Literature DB >> 33479368

Behavioral arrest and a characteristic slow waveform are hallmark responses to selective 5-HT2A receptor activation.

April Contreras1, Matthew Khumnark1, Rochelle M Hines1, Dustin J Hines2.   

Abstract

Perception, emotion, and mood are powerfully modulated by serotonin receptor (5-HTR) agonists including hallucinogens. The 5-HT2AR subtype has been shown to be central to hallucinogen action, yet the precise mechanisms mediating the response to 5-HT2AR activation remain unclear. Hallucinogens induce the head twitch response (HTR) in rodents, which is the most commonly used behavioral readout of hallucinogen pharmacology. While the HTR provides a key behavioral signature, less is known about the meso level changes that are induced by 5-HT2AR activation. In response to administration of the potent and highly selective 5-HT2AR agonist 25I-NBOH in mice, we observe a disorganization of behavior which includes frequent episodes of behavioral arrest that consistently precede the HTR by a precise interval. By combining behavioral analysis with electroencephalogram (EEG) recordings we describe a characteristic pattern composed of two distinctive EEG waveforms, Phase 1 and Phase 2, that map onto behavioral arrest and the HTR respectively, with the same temporal separation. Phase 1, which underlies behavioral arrest, is a 3.5-4.5 Hz waveform, while Phase 2 is slower at 2.5-3.2 Hz. Nicotine pretreatment, considered an integral component of ritualistic hallucinogen practices, attenuates 25I-NBOH induced HTR and Phase 2 waveforms, yet increases behavioral arrest and Phase 1 waveforms. Our results suggest that in addition to the HTR, behavioral arrest and characteristic meso level slow waveforms are key hallmarks of the response to 5-HT2AR activation. Increased understanding of the response to serotonergic hallucinogens may provide mechanistic insights into perception and hallucinations, as well as regulation of mood.

Entities:  

Year:  2021        PMID: 33479368     DOI: 10.1038/s41598-021-81552-6

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  46 in total

Review 1.  Structure and function of the brain serotonin system.

Authors:  B L Jacobs; E C Azmitia
Journal:  Physiol Rev       Date:  1992-01       Impact factor: 37.312

Review 2.  Studying the effects of classic hallucinogens in the treatment of alcoholism: rationale, methodology, and current research with psilocybin.

Authors:  Michael P Bogenschutz
Journal:  Curr Drug Abuse Rev       Date:  2013-03

3.  An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat.

Authors:  E C Azmitia; M Segal
Journal:  J Comp Neurol       Date:  1978-06-01       Impact factor: 3.215

4.  Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer.

Authors:  Charles S Grob; Alicia L Danforth; Gurpreet S Chopra; Marycie Hagerty; Charles R McKay; Adam L Halberstadt; George R Greer
Journal:  Arch Gen Psychiatry       Date:  2010-09-06

5.  Serotonergic and non-serotonergic projections from the nucleus raphe dorsalis to the caudate-putamen complex in the rat, studied by a combined immunofluorescence and fluorescent retrograde axonal labeling technique.

Authors:  H W Steinbusch; D van der Kooy; A A Verhofstad; A Pellegrino
Journal:  Neurosci Lett       Date:  1980-09       Impact factor: 3.046

Review 6.  Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens.

Authors:  Adam L Halberstadt; Mark A Geyer
Journal:  Neuropharmacology       Date:  2011-01-20       Impact factor: 5.250

Review 7.  Therapeutic Applications of Classic Hallucinogens.

Authors:  Michael P Bogenschutz; Stephen Ross
Journal:  Curr Top Behav Neurosci       Date:  2018

Review 8.  Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles.

Authors:  David Baumeister; Georgina Barnes; Giovanni Giaroli; Derek Tracy
Journal:  Ther Adv Psychopharmacol       Date:  2014-08

9.  Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action.

Authors:  F X Vollenweider; M F Vollenweider-Scherpenhuyzen; A Bäbler; H Vogel; D Hell
Journal:  Neuroreport       Date:  1998-12-01       Impact factor: 1.837

10.  The serotonin neurons in nucleus raphe dorsalis of adult rat: a light and electron microscope radioautographic study.

Authors:  L Descarries; K C Watkins; S Garcia; A Beaudet
Journal:  J Comp Neurol       Date:  1982-05-20       Impact factor: 3.215

View more
  1 in total

1.  Psilocin acutely alters sleep-wake architecture and cortical brain activity in laboratory mice.

Authors:  Christopher W Thomas; Cristina Blanco-Duque; Benjamin J Bréant; Guy M Goodwin; Trevor Sharp; David M Bannerman; Vladyslav V Vyazovskiy
Journal:  Transl Psychiatry       Date:  2022-02-23       Impact factor: 6.222

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.